Safety and Efficacy of Apatinib Monotherapy for Unresectable, Metastatic Esophageal Cancer: A Single-Arm, Open-Label, Phase II Study.

CONCLUSION: Apatinib was effective as second- or further-line treatment for advanced esophageal cancer.
PMID: 32342599 [PubMed - as supplied by publisher]

Source: The Oncologist - April 26, 2020 Category: Cancer & Oncology Authors: Yanwei L, Feng H, Ren P, Yue J, Zhang W, Tang P, Shang X, Pang Q, Liu D, Chen C, Pan Z, Tao YZ Tags: Oncologist Source Type: research